Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Bristol-Myers Squibb sell Barclays PLC

Start price
€42.92
22.08.24 / 50%
Target price
€37.80
22.08.25
Performance (%)
-4.19%
End price
€41.12
23.08.25
Summary
This prediction ended on 23.08.25 with a price of €41.12. With a performance of -4.19%, the SELL prediction by Barclays_PLC was trending in the right direction. Dividends of €1.15 are taken into consideration when calculating the performance. Barclays_PLC has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Bristol-Myers Squibb -0.290% -0.290% -16.924%
iShares Core DAX® 0.734% -0.964% 17.910%
iShares Nasdaq 100 -2.686% -2.409% 4.267%
iShares Nikkei 225® -2.261% -4.038% 10.420%
iShares S&P 500 -1.346% -1.510% 1.615%

Comments by Barclays_PLC for this prediction

In the thread Bristol-Myers Squibb diskutieren
Prediction Sell
Perf. (%) -4.19%
Target price 37.800
Change
Ends at 22.08.25

Bristol-Myers Squibb (NYSE: BMY) had its price target raised by analysts at Barclays PLC from $41.00 to $42.00. They now have an "underweight" rating on the stock.
Ratings data for BMY provided by MarketBeat

In the thread Trading Bristol-Myers Squibb
Prediction Sell
Perf. (%) -4.19%
Target price 37.800
Change
Ends at 22.08.25

Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten

Stopped prediction by Barclays_PLC for Bristol-Myers Squibb

Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€48.85
07.10.24
€39.19
07.10.25
-20.99%
08.10.25